GENX logo

Genix Pharmaceuticals Corporation Stock Price

TSXV:GENX Community·CA$1.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GENX Share Price Performance

CA$0.03
-0.01 (-25.00%)
CA$0.03
-0.01 (-25.00%)
Price CA$0.03

GENX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with imperfect balance sheet.

5 Risks
0 Rewards

Genix Pharmaceuticals Corporation Key Details

CA$68.0

Revenue

CA$183.1k

Cost of Revenue

-CA$183.0k

Gross Profit

-CA$94.2k

Other Expenses

-CA$88.8k

Earnings

Last Reported Earnings
Jul 31, 2025
Next Reporting Earnings
n/a
-0.0014
-269,108.82%
-130,527.94%
-71.7%
View Full Analysis

About GENX

Founded
1993
Employees
n/a
CEO
Sina Pirooz
WebsiteView website
www.genixpharm.com

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to support kidney health; and Sucanon, a herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. The company was incorporated in 1993 and is based in Vancouver, Canada.

Recent GENX News & Updates

Recent updates

No updates